TGF-β1 Reverses the Effects of Matrix Anchorage on the Gene Expression of Decorin and Procollagen Type I in Tendon Fibroblasts
- 1 February 2005
- journal article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 431 (431) , 226-232
- https://doi.org/10.1097/01.blo.0000145887.48534.6f
Abstract
Transforming growth factor-beta1 is known for its effect on the production of extracellular matrix in tendons. Elevated levels of transforming growth factor-beta1 have been reported in tendon adhesion and tendinosis, which suggests that transforming growth factor-beta1 plays an important role in matrix disturbances. Tendon adhesion involves excessive collagen deposition, whereas tendinosis is associated with increased proteoglycan deposition. It seems that other factors also may affect matrix deposition and modulate the effects of transforming growth factor-beta1. We assessed whether matrix anchorage to Type I collagen or fibronectin could change the gene expression of matrix proteins in tendon fibroblasts, and studied whether the effects of transforming growth factor-beta1 were altered by matrix anchorage. Human patellar tendon fibroblast cultures were prepared in different cell anchorages, and the cellular responses to transforming growth factor-beta1 were measured as gene expression of procollagen Type I, Type III, decorin, and biglycan by real-time reverse transcriptase-polymerase chain reaction. Fibronectin anchorage significantly increased the messenger ribonucleic acid level of decorin, and the messenger ribonucleic acid level of procollagen Type I was decreased by matrix anchorage to either fibronectin or Type I collagen. Transforming growth factor-beta1 increased the messenger ribonucleic acid level of procollagen Type I in Type I collagen-coated plates, but it suppressed the messenger ribonucleic acid level of decorin in fibronectin-coated plates. These findings suggest that interaction of matrix anchorage and transforming growth factor-beta1 is an important determinant of matrix deposition in healing tendons and the development of matrix disturbances in tendons.This publication has 34 references indexed in Scilit:
- Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcomeGene Therapy, 2003
- High-throughput transgene copy number estimation by competitive PCRPlant Molecular Biology Reporter, 2002
- TGF-β alters collagen XII and XIV mRNA levels in cultured equine tenocytesMatrix Biology, 2002
- Differences in Mesenchymal Tissue RepairPublished by Wolters Kluwer Health ,2001
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: A rat patellar tendon modelActa Orthopaedica, 2000
- Studies in Flexor Tendon Wound Healing: Neutralizing Antibody to TGF-β1 Increases Postoperative Range of MotionPlastic and Reconstructive Surgery, 2000
- Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3Journal of Investigative Dermatology, 1999
- Gene Expression of Transforming Growth Factor Beta-1 in Rabbit Zone II Flexor Tendon Wound Healing: Evidence for Dual Mechanisms of RepairPlastic and Reconstructive Surgery, 1997
- TGF-β1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: A fibronectin matrix-dependent eventJournal of Cellular Physiology, 1997